Workflow
安图生物(603658) - 2022 Q3 - 季度财报
AutobioAutobio(SH:603658)2022-10-25 16:00

Financial Performance - The company's operating revenue for Q3 2022 was ¥1,211,231,405.06, representing a year-on-year increase of 19.02%[4] - The net profit attributable to shareholders for the same period was ¥365,365,458.84, reflecting a growth of 20.23% compared to the previous year[4] - The net profit after deducting non-recurring gains and losses was ¥354,873,633.48, with a year-on-year increase of 15.47%[4] - The basic earnings per share for Q3 2022 was ¥0.63, up 21.15% from the same period last year[5] - Operating profit for Q3 2022 was ¥1,024,790,143.90, up 26.5% from ¥809,742,616.52 in Q3 2021[17] - Net profit attributable to shareholders of the parent company for Q3 2022 was ¥898,886,168.12, an increase of 25.4% compared to ¥716,573,599.07 in Q3 2021[17] - The total comprehensive income for Q3 2022 was ¥916,703,080.59, compared to ¥724,411,245.50 in Q3 2021, reflecting a growth of 26.6%[18] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥10,229,578,454.31, an increase of 10.80% compared to the end of the previous year[5] - The total liabilities stood at CNY 6.15 billion, with short-term borrowings slightly increasing to CNY 100.08 million from CNY 100.06 million[13] - The total liabilities increased to ¥2,571,907,750.58 in Q3 2022 from ¥1,829,490,502.60 in Q3 2021, reflecting a growth of 40.5%[15] - The company's total equity reached ¥7,657,670,703.73 in Q3 2022, compared to ¥7,403,203,912.94 in Q3 2021, marking an increase of 3.4%[15] - The company's total liabilities and equity reached ¥10,229,578,454.31 in Q3 2022, up from ¥9,232,694,415.54 in Q3 2021, indicating a growth of 10.8%[15] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥1,008,547,134.85, reflecting an increase of 8.01%[5] - The net cash flow from operating activities for the first three quarters of 2022 was CNY 1,008,547,134.85, an increase of 8.0% compared to CNY 933,770,922.23 in the same period of 2021[20] - Total cash inflow from operating activities reached CNY 3,617,051,516.19, up from CNY 3,111,829,528.21, reflecting a growth of 16.2% year-over-year[20] - Cash outflow for purchasing goods and services was CNY 1,177,377,937.04, compared to CNY 1,052,019,729.95 in the previous year, indicating a rise of 11.9%[20] - The net cash flow from investment activities was -CNY 855,683,891.09, worsening from -CNY 292,539,347.14 in the same period last year[21] - The net cash flow from financing activities was -CNY 75,024,124.23, an improvement from -CNY 429,197,726.14 in the previous year[21] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 38,333[8] - The company’s major shareholder, Zhengzhou Antu Industrial Group, holds 323,821,073 shares, representing a significant portion of the total shares outstanding[10] - The company has a share repurchase account holding 5,260,910 shares, accounting for approximately 0.90% of the total share capital[10] - The report indicates that there are no known relationships or concerted actions among the top ten shareholders, ensuring independent ownership structures[10] Research and Development - Research and development expenses for the first three quarters of 2022 were ¥396,959,203.55, up 17.4% from ¥337,848,595.48 in the same period of 2021[16] Other Financial Metrics - The company had a weighted average return on equity of 4.97% for the quarter, an increase of 0.54 percentage points year-on-year[5] - Non-recurring gains for Q3 2022 totaled ¥10,491,825.36, with a year-to-date total of ¥38,789,436.10[7] - The company reported a net impairment loss of ¥15,916,240.94 in Q3 2022, compared to a loss of ¥11,890,686.31 in Q3 2021[17] - The company's cash and cash equivalents reached CNY 849.35 million, up from CNY 769.40 million year-over-year, indicating a growth of approximately 10.5%[12] - Accounts receivable increased to CNY 1.13 billion from CNY 989.06 million, representing a rise of about 14.5%[12] - Inventory levels rose to CNY 787.30 million, compared to CNY 589.34 million in the previous year, marking an increase of approximately 33.6%[13] - The total current assets were reported at CNY 6.15 billion, up from CNY 5.56 billion, which is an increase of around 10.7%[13] - The company’s long-term equity investments increased significantly to CNY 8.60 million from CNY 1.72 million, reflecting a growth of approximately 400%[13]